Antibody Drug Conjugates Market Expansion with New Cancer Therapies
North America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...
0 Σχόλια 0 Μοιράστηκε 44 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
Προωθημένο